Trends in survival of patients diagnosed with cancer of the digestive organs in the Nordic countries 1964–2003 followed up to the end of 2006

References

• Engholm G, Ferlay J, Christensen N, Bray F, Klint Å, Olafsdottir E, . NORDCAN: Cancer incidence, mortality, and prevalence in the Nordic countries. Version 3.3. Association of Nordic Cancer Registries, Danish Cancer Society. 2008. Available from: www.ancr.nu.
   Google Scholar
• Li D, Xie K, Wolff R, Abbruzzese JL. Pancreatic cancer. Lancet 2004;363:1049–57.
   PubMed Web of Science ®Google Scholar
• Thun MJ, Henley SJ. Tobacco. Schottenfeld D, Fraumeni JF Jr. Cancer epidemiology and prevention. 3rd Oxford: Oxford University Press; 2006. 217–42.
   Google Scholar
• Dreyer L, Winther JF, Pukkala E, Andersen A. Avoidable cancers in the Nordic countries. Tobacco smoking. APMIS Suppl 1997;76:9–47.
   PubMedGoogle Scholar
• Marshall JR, Freudenheim J. Alcohol. Schottenfeld D, Fraumeni JF Jr. Cancer epidemiology and prevention. 3rd Oxford: Oxford University Press; 2006. 243–58.
   Google Scholar
• Dreyer L, Winther JF, Andersen A, Pukkala E. Avoidable cancers in the Nordic countries. Alcohol consumption. APMIS Suppl 1997;76:48–67.
   PubMedGoogle Scholar
• London WT, McGlynn KA. Liver Cancer. Schottenfeld D, Fraumeni JF Jr. Cancer epidemiology and prevention. 3rd Oxford: Oxford University Press; 2006. 763–86.
   Google Scholar
• Willet WC. Diet and nutrition. Schottenfeld D, Fraumeni JF Jr. Cancer epidemiology and prevention. 3rd Oxford: Oxford University Press; 2006. 405–21.
   Google Scholar
• Shibata A, Parsonnet J. Stomach cancer. Schottenfeld D, Fraumeni JF Jr. Cancer epidemiology and prevention. 3rd Oxford: Oxford University Press; 2006. 707–20.
   Google Scholar
• Food, nutrition, physical activity, and the prevention of cancer: A global perspective. Washington DC: World Cancer Research Fund/American Institute for Cancer Research; 2007.
   Google Scholar
• Lee I-M, Oguma Y. Physical activity. Schottenfeld D, Fraumeni JF Jr. Cancer epidemiology and prevention. 3rd Oxford: Oxford University Press; 2006. 449–67.
   Google Scholar
• Beebe-Dimmer JL, Schottenfeld D. Cancers of the small intestine. Schottenfeld D, Fraumeni JF Jr. Cancer epidemiology and prevention. 3rd Oxford: Oxford University Press; 2006. 801–8.
   Google Scholar
• Hsing AW, Rashid A, Devesa SS, Fraumeni JF Jr. Biliary tract cancer. Schottenfeld D, Fraumeni JF Jr. Cancer epidemiology and prevention. 3rd Oxford: Oxford University Press; 2006. 787–800.
   Google Scholar
• Sant M, Allemani C, Santaquilani M, Knijn A, Marchesi F, Capocaccia R. EUROCARE-4. Survival of cancer patients diagnosed in 1995–1999. Results and commentary. Eur J Cancer 2009;45:931–91.
   PubMed Web of Science ®Google Scholar
• Engeland A, Haldorsen T, Tretli S, Hakulinen T, Hörte LG, Luostarinen T, . Prediction of cancer mortality in the Nordic countries up to the years 2000 and 2010, on the basis of relative survival analysis. A collaborative study of the five Nordic Cancer Registries. APMIS Suppl 1995;49:1–161.
   PubMedGoogle Scholar
• Engeland A, Haldorsen T, Dickman PW, Hakulinen T, Möller TR, Storm HH, . Relative survival of cancer patients—a comparison between Denmark and the other Nordic countries. Acta Oncol 1998;37:49–59.
   PubMed Web of Science ®Google Scholar
• Engholm G, Kejs AM, Brewster DH, Gaard M, Holmberg L, Hartley R, . Colorectal cancer survival in the Nordic countries and the United Kingdom: Excess mortality risk analysis of 5 year relative period survival in the period 1999 to 2000. Int J Cancer 2007;121:1115–22.
   PubMed Web of Science ®Google Scholar
• Engholm G, Gislum M, Bray F, Hakulinen T. Trends in the survival of patients diagnosed with cancer in the Nordic countries 1964–2003 followed up to the end of 2006. Material and methods. Acta Oncol 2010.
   Google Scholar
• Corazziari I, Quinn M, Capocaccia R. Standard cancer patient population for age standardising survival ratios. Eur J Cancer 2004;40:2307–16.
   PubMed Web of Science ®Google Scholar
• Blot WJ, McLaughlin JK, Fraumeni JF Jr. Esophageal cancer. Schottenfeld D, Fraumeni JF Jr. Cancer epidemiology and prevention. 3rd Oxford: Oxford University Press; 2006. 697–706.
   Google Scholar
• Falk J, Carstens H, Lundell L, Albertsson M. Incidence of carcinoma of the eosophagus and gastric cardia. Changes over time and geographical differences. Acta Oncol 2007;46:1070–4.
   PubMed Web of Science ®Google Scholar
• Stockeld D, Backman L, Fagerberg J, Granström L. Esophageal cancer in Stockholm county 1978–95. Acta Oncol 2007;46:1075–84.
   PubMed Web of Science ®Google Scholar
• Tønnesen H, Nielsen PR, Lauritzen JB, Møller AM. Smoking and alcohol intervention before surgery: Evidence for best practice. Br J Anaesth 2009;102:297–306.
   PubMedGoogle Scholar
• Lauren P. The two histological main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. APMIS 1965;64:31–49.
   Google Scholar
• Nikulasson S, Hallgrimsson J, Tulinius H, Sigvaldason H, Olafsdottir G. Tumours in Iceland. 16. Malignant tumours of the stomach. Histological classification and description of epidemiological changes in a high-risk population during 30 years. APMIS 1992;100:930–41.
   PubMedGoogle Scholar
• Pinheiro PS, van der Heijden LH, Coebergh JW. Unchanged survival of gastric cancer in the southeastern Netherlands since 1982: Result of differential trends in incidence according to Lauren type and subsite. Int J Cancer 1999;84:28–32.
   PubMedGoogle Scholar
• Verdecchia A, Corazziari I, Gatta G, Lisi D, Faivre J, Forman D. Explaining gastric cancer survival differences among European countries. Int J Cancer 2004;109:737–41.
   PubMed Web of Science ®Google Scholar
• Howson CP, Hiyama T, Wynder EL. The decline in gastric cancer: Epidemiology of an unplanned triumph. Epidemiol Rev 1986;8:1–27.
   PubMed Web of Science ®Google Scholar
• Faivre J, Forman D, Esteve J, Gatta G. Survival of patients with oesophageal and gastric cancers in Europe. EUROCARE Working Group. Eur J Cancer 1998;34:2167–75.
   PubMed Web of Science ®Google Scholar
• De Vita F, Giuliani F, Galizia G, Belli C, Aurilio G, Santabarbara G, . Neo-adjuvant and adjuvant chemotherapy of gastric cancer. Ann Oncol 2007;18(Suppl 6): vi120–3.
   PubMedGoogle Scholar
• Foukakis T, Lundell L, Gubanski M, Lind PA. Advances in the treatment of patients with gastric adenocarcinoma. Acta Oncol 2007;46:277–85.
   PubMed Web of Science ®Google Scholar
• Verdecchia A, Guzzinati S, Francisci S, De Angelis R, Bray F, Allemani C, . Survival trends in European cancer patients diagnosed from 1988 to 1999. Eur J Cancer 2009;45:1042–66.
   PubMed Web of Science ®Google Scholar
• Talbäck M, Stenbeck M, Rosén M. Up-to-date long- term survival of cancer patients: An evaluation of period analysis on Swedish Cancer Registry data. Eur J Cancer 2004;40:1361–72.
   PubMed Web of Science ®Google Scholar
• Singhal N, Singhal D. Adjuvant chemotherapy for small intestine adenocarcinoma. Cochrane Database Syst Rev 2007;3:CD005202.
   PubMedGoogle Scholar
• Karim-Kos HE, de Vries E, Soerjomataram I, Lemmens V, Siesling S, Coebergh JW. Recent trends of cancer in Europe: A combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer 2008;44:1345–89.
   PubMed Web of Science ®Google Scholar
• Harling H, Bülow S, Møller LN, Jørgensen T. Hospital volume and outcome of rectal cancer surgery in Denmark 1994–99. Colorectal Dis 2005;7:90–5.
   PubMedGoogle Scholar
• Dickman PW, Adami HO. Interpreting trends in cancer patient survival. J Intern Med 2006;260:103–17.
   PubMed Web of Science ®Google Scholar
• Dahlberg M, Glimelius B, Påhlman L. Changing strategy for rectal cancer is associated with improved outcome. Br J Surg 1999;86:379–84.
   PubMed Web of Science ®Google Scholar
• Martling A, Cedermark B, Johansson H, Rutqvist LE, Holm T. The surgeon as a progonostic factor after the introduction of total mesorectal excision in the treatment of rectal cancer. Br J Surg 2002;89:1008–13.
   PubMed Web of Science ®Google Scholar
• Wibe A, Møller B, Norstein J, Carlsen E, Wiig JN, . A national strategic change in treatment policy for rectal cancer—implemetation of total mesorectal excision as a routine treatment in Norway. A national audit. Dis Colon Rectum 2002;45:857–66.
   PubMed Web of Science ®Google Scholar
• Wibe A, Carlsen E, Dahl O, Tveit KM, Weedon-Fekjaer H, Hestvik UE, . Nationwide quality assurance of rectal cancer treatment. Colorectal Dis 2006;8:224–9.
   PubMed Web of Science ®Google Scholar
• Folkesson J, Engholm G, Ehrnrooth E, Kejs AM, Pahlman L, Harling H, . Rectal cancer survival in the Nordic countries and Scotland. Int J Cancer 2009;125:2406–12.
   PubMed Web of Science ®Google Scholar
• National Guidelines for treatment of colon- and rectal cancer. Stockholm, Sweden: National Board of Health and Welfare; 2007.
   Google Scholar
• Hussain SA, Ferry DR, El-Gazzaz G, Mirza DF, James ND, McMaster P, . Hepatocellular carcinoma. Ann Oncol 2001;12:161–72.
   PubMed Web of Science ®Google Scholar
• Wood R, Fraser LA, Brewster DH, Garden OJ. Epidemiology of gallbladder cancer and trends in cholecystectomy rates in Scotland, 1968–1998. Eur J Cancer 2003;39:2080–6.
   PubMed Web of Science ®Google Scholar
• Chua YJ, Zalcberg JR. Pancreatic cancer—is the wall crumbling? Ann Oncol 2008;19:1224–30.
   PubMed Web of Science ®Google Scholar
• Nagenthiraja K, Ewertz M, Engholm G, Storm HH. Incidence and mortality of pancreatic cancer in the Nordic countries 1971–2000. Acta Oncol 2007;46:1064–9.
   PubMed Web of Science ®Google Scholar
• Carpelan-Holmström M, Nordling S, Pukkala E, Sankila R, Lüttges J, Klöppel G, . Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer Registry. Gut 2005;54:385–7.
   PubMed Web of Science ®Google Scholar
• Søreide K, Aagnes B, Møller B, Westgaard A, Bray F. Epidemiology of pancreatic cancer in Norway: Trends in incidence, basis of diagnosis and survival 1965–2007. Scand J Gastroenterol 2010;45:82–92.
   PubMed Web of Science ®Google Scholar